|
| Status |
Public on Nov 11, 2024 |
| Title |
Differential KEAP1/NRF2-mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy |
| Organisms |
Homo sapiens; Mus musculus |
| Experiment type |
Expression profiling by high throughput sequencing
Expression profiling by array
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| Web link |
https://doi.org/10.1101/2024.11.06.621846
|
| |
|
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| |
| Submission date |
Oct 30, 2024 |
| Last update date |
Nov 12, 2024 |
| Contact name |
Nikolas Gunkel |
| E-mail(s) |
n.gunkel@dkfz-heidelberg.de
|
| Organization name |
German Cancer Research Center (DKFZ)
|
| Department |
Research Group Cancer Drug Development
|
| Street address |
Im Neuenheimer Feld 280
|
| City |
Heidelberg |
| State/province |
*Not Applicable |
| ZIP/Postal code |
69120 |
| Country |
Germany |
| |
|
| Platforms (3) |
| GPL23159 |
[Clariom_S_Human] Affymetrix Clariom S Assay, Human (Includes Pico Assay) |
| GPL24247 |
Illumina NovaSeq 6000 (Mus musculus) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (74)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE279100 |
Differential KEAP1/NRF2-mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy [seq] |
| GSE280642 |
Differential KEAP1/NRF2-mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapy [array] |
|
| Relations |
| BioProject |
PRJNA1179864 |
Less...
More...